Department of Hepatobiliary Surgery, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010000, China.
Department of Geriatric Medicine, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010000, China.
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20193295.
The microRNA, miR-139-5p, has been proved to play important roles in regulating tumor progression, including prostate cancer, osteosarcoma, esophageal cancer, and so on, but its correlation of hepatocellular carcinoma (HCC) still remains unclear. Here we found that hsa-miR-139-5p (miR-139-5p) was decreased in HCC samples compared with normal liver tissues, and a lower expression of miR-139-5p was connected to a poorer prognosis. Mechanism study indicated that a decreased/increased miR-139-5p could increase/decrease HCC cells invasion and proliferation capacities via increasing SLITRK4 expression, what's more, the reverse assays also confirmed the conclusion when we knocked down SLITRK4 in the miR-139-5p low-expression cells. Luciferase assay confirmed that miR-139-5p could directly bind to the 3'UTR of SLITRK4 mRNA to regulate its expression. Together, these findings show the importance of miR-139-5p/SLITRK4 pathway in HCC growth and progression and may provide new targets for us to better arrange the progression of HCC.
微小 RNA,miR-139-5p,已被证明在调节肿瘤进展中发挥重要作用,包括前列腺癌、骨肉瘤、食管癌等,但它与肝细胞癌(HCC)的相关性仍不清楚。在这里,我们发现 hsa-miR-139-5p(miR-139-5p)在 HCC 样本中比正常肝组织中减少,miR-139-5p 的低表达与预后较差有关。机制研究表明,通过增加 SLITRK4 的表达,减少/增加 miR-139-5p 可以增加/减少 HCC 细胞的侵袭和增殖能力,此外,当我们在 miR-139-5p 低表达细胞中敲低 SLITRK4 时,反向实验也证实了这一结论。荧光素酶实验证实,miR-139-5p 可以直接结合 SLITRK4 mRNA 的 3'UTR 来调节其表达。总之,这些发现表明 miR-139-5p/SLITRK4 通路在 HCC 的生长和进展中具有重要意义,并可能为我们更好地安排 HCC 的进展提供新的靶点。